Carcinomatosis: Clinical Trials

9 trials for Carcinomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 3 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Completed 1
Phase 12Recruiting 1, Withdrawn 1
Early Phase 11Active not recruiting 1
Not applicable1Completed 1

Follow Carcinomatosis: new trials by email Literature Review of Carcinomatosis trials Research Report on Carcinomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
Cyclophosphamide, Fludarabine, Cetuximab - Colorectal Cancer, Peritoneal Metastases
Phase 1 / Phase 2RecruitingM.D. Anderson Cancer Center282026-04-202026-10-05
Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis
VG2025 - Advanced Solid Tumor, Carcinomatosis
Phase 1WithdrawnM.D. Anderson Cancer Center2024-09-302025-02-17
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
Paclitaxel, Dexamethasone, Diphenhydramine - Gastric Adenocarcinoma, Carcinomatosis
Phase 2RecruitingM.D. Anderson Cancer Center302023-09-082026-05-22
Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy
Biospecimen Collection, Pain Assessment, Questionnaire Administration - Appendix Carcinoma, Carcinomatosis
CompletedM.D. Anderson Cancer Center242021-08-102024-02-13
Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)
ROTEM parameters, platelet function assay (PFA-100), von Willebrand and Factor XIII - Coagulation Disorder, Carcinomatosis
CompletedHospitales Universitarios Virgen del Rocío462020-03-272021-03-09
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Adavosertib, Laboratory Biomarker Analysis - Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma
Early Phase 1Active not recruitingM.D. Anderson Cancer Center382016-02-042026-10-06
Immunologic Profile of Peritoneal Cancer
HIPEC - Carcinomatosis
UnknownMercyOne Des Moines Medical Center602016-01-012020-09-23
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites
BNP, SAAG, ascites total protein, echocardiography - Heart Failure, Liver Cirrhosis
Not applicableCompletedUniversity of Sao Paulo2782010-06-012012-12-20
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
Octreotide LAR, Octreotide (Immediate release), methylprednisolone - Peritoneal Neoplasms, Intestinal Obstruction
Phase 2CompletedNovartis Pharmaceuticals642005-09-012011-09-23

Narrower conditions

Carcinoma (9)  ·  Colorectal Neoplasms (2)  ·  Appendiceal Neoplasms (1)  ·  Ascites (1)  ·  Colorectal Cancer, Hereditary Nonpolyposis, Type 6 (1)  ·  Fallopian Tube Neoplasms (1)  ·  Heart Failure (1)  ·  Hemostatic Disorders (1)  ·  Intestinal Obstruction (1)  ·  Liver Cirrhosis (1)  ·  Peritoneal Neoplasms (1)  ·  Stomach Neoplasms (1)

Broader conditions

Neoplasms (9)  ·  Neoplasms by Histologic Type (9)  ·  Neoplasms, Glandular and Epithelial (9)  ·  Digestive System Diseases (4)  ·  Neoplasms by Site (4)  ·  Digestive System Neoplasms (3)  ·  Gastrointestinal Diseases (3)  ·  Intestinal Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Colonic Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Intestinal Neoplasms (2)  ·  Rectal Diseases (2)  ·  Abdominal Neoplasms (1)  ·  Adnexal Diseases (1)

Interventions

Calcium Dobesilate (1)  ·  Cetuximab (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Diphenhydramine (1)  ·  Famotidine (1)  ·  Hyperthermic Intraperitoneal Chemotherapy (1)  ·  Methylprednisolone (1)  ·  Octreotide (1)  ·  Paclitaxel (1)  ·  adavosertib (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)

Sponsors

M.D. Anderson Cancer Center (5)  ·  Hospitales Universitarios Virgen del Rocío (1)  ·  MercyOne Des Moines Medical Center (1)  ·  Novartis Pharmaceuticals (1)  ·  University of Sao Paulo (1)

Countries

United States (6)  ·  Brazil (1)  ·  France (1)  ·  Spain (1)

Top investigators

Alberto Q. Farias, MD, PhD (1)  ·  Brian Badgwell, MD (1)  ·  Jan Franko, MD, PhD (1)  ·  Juan P Cata (1)  ·  Paula M Smith, MD (1)  ·  Shannon N Westin (1)  ·  Siqing Fu, MD,PHD (1)

Results publications

PMID 23907731, PMID 32379297, PMID 32696309